Original Research
Published on 28 Jan 2026
Activity of Biocidin® against microbial biofilms
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2025.1692653
- 771 views
Type at least 3 characters
15 articles
articles
Review
Accepted on 27 Jan 2026
Overcoming Candidal Biofilm Resistance: Targeting Persister Cells with Probiotic-Derived Metabolites
in Antibiotic Development
Frontiers in Antibiotics
Review
Accepted on 20 Jan 2026
Natural Product Based Approaches to Overcome Candida glabrata and Emerging AMR Threats
in Antibiotic Development
Frontiers in Antibiotics
- 139 views
Perspective
Published on 29 Apr 2025
Data transparency and reproducibility in health research: bridging the gap for early-career researchers
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2025.1562002
- 2,412 views
Original Research
Published on 15 Jan 2025
Analysis of engineered T7 bacteriophages containing genetic sequences encoding antimicrobial peptides
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2024.1515874
- 3,010 views
- 2 citations
Original Research
Published on 24 Jun 2024
Genomic modifications for enhanced antibiotic production in rifamycin derivative-producing Amycolatopsis mediterranei S699 strains: focusing on rifQ and rifO genes
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2024.1399139
- 4,681 views
- 2 citations
Original Research
Published on 08 May 2024
Mycobactin analogue interacting with siderophore efflux-pump protein: insights from molecular dynamics simulations and whole-cell assays
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2024.1362516
- 4,858 views
- 1 citation
Original Research
Published on 08 Apr 2024
Targeting synthesis of the Chromosome Replication Initiator Protein DnaA by antisense PNA-peptide conjugates in Escherichia coli
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2024.1384390
- 3,217 views
- 4 citations
Original Research
Published on 21 Aug 2023
Gold complex compounds that inhibit drug-resistant Staphylococcus aureus by targeting thioredoxin reductase
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2023.1179354
- 4,041 views
- 7 citations
Original Research
Published on 17 Jul 2023
Nanotherapeutic delivery of antibiotic cocktail enhances intra-macrophage killing of Mycobacterium marinum
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2023.1162941
- 2,517 views
- 2 citations
Original Research
Published on 12 Jul 2023
Screening Amazon rainforest plant extracts for antimicrobial activity: a 15-year commitment to the Brazilian biodiversity
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2023.1122400
- 6,868 views
- 5 citations
Brief Research Report
Published on 22 Mar 2023
Antimicrobial activity of a new class of synthetic retinoid antibiotics and comparator agents against ocular staphylococci
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2023.1101450
- 2,707 views
- 1 citation
Review
Published on 09 Feb 2023
Repurposing inhibitors of phosphoinositide 3-kinase as adjuvant therapeutics for bacterial infections
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2023.1135485
- 2,806 views
- 7 citations
Mini Review
Published on 30 Jan 2023
Resistance-resistant antibacterial treatment strategies
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2023.1093156
- 8,879 views
- 15 citations
Original Research
Published on 09 Sep 2022
Implications of drug-induced phenotypical resistance: Is isoniazid radicalizing M. tuberculosis?
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2022.928365
- 3,076 views
- 2 citations